Snowball logo
logo
CTXR_logo

Citius Pharmaceuticals, Inc

CTXR NASDAQ
$0.9622+$0.0947  (10.92%)

Frequently asked questions

What sector does Citius Pharmaceuticals, Inc (CTXR) operate in?

Citius Pharmaceuticals, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Citius Pharmaceuticals, Inc (CTXR) current stock price?

As of the latest data, Citius Pharmaceuticals, Inc stock price is $0.96, with a previous close of $0.87. Citius Pharmaceuticals, Inc gained $0.09 in the last trading session, representing a 10.92% increase.

What is Citius Pharmaceuticals, Inc (CTXR) current market capitalization?

Citius Pharmaceuticals, Inc market cap is approximately 21.53 million.

What is Citius Pharmaceuticals, Inc (CTXR) Earnings Per Share (EPS)?

The trailing EPS is -$2.46, and the forward EPS is $2.79.

What is Citius Pharmaceuticals, Inc (CTXR) EBITDA?

Citius Pharmaceuticals, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -8.45 million.

Does Citius Pharmaceuticals, Inc (CTXR) pay dividends?

No. Citius Pharmaceuticals, Inc does not pay a dividend.

How did Citius Pharmaceuticals, Inc (CTXR) perform in its most recent earnings report?

In the last report (December 31, 2025), Citius Pharmaceuticals, Inc posted an EPS surprise of -26.67% and a revenue surprise of 14.16%.

What is Citius Pharmaceuticals, Inc (CTXR) beta (volatility) score?

Citius Pharmaceuticals, Inc has a beta of 1.558, suggesting it is more volatile than the market.